Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Jacob

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|July 5, 2014
PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension arrayTatiana Pochechueva, Alexander Chinarev, Nicolai Bovin, et al.
Nature Methods|October 31, 2025
High-resolution imaging mass cytometry to map subcellular structuresAlina Bollhagen, James Whipman, Ricardo Coelho, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2019
Outcome in serous ovarian cancer is not associated with LATS expressionCéline Montavon, Gregor R Stricker, Andreas Schoetzau, et al.
International Journal of Oncology|June 1, 2022
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell linesAndré Fedier, Nadia Maggi, Alessandra Tozzi, et al.
Plos One|April 5, 2013
Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell linesFrancis Jacob, Rea Guertler, Stephanie Naim, et al.
Molecular Oncology|October 5, 2020
High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancerFrancis Jacob, Rosa Lina Marchetti, André B Kind, et al.
Molecular & Cellular Proteomics : MCP|May 24, 2014
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation statusMerrina Anugraham, Francis Jacob, Sheri Nixdorf, et al.
Cancer Treatment Reviews|December 16, 2022
Low grade serous ovarian cancer - A rare disease with increasing therapeutic optionsTibor A Zwimpfer, Ori Tal, Franziska Geissler, et al.
Gynecologic Oncology|March 23, 2011
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical settingFrancis Jacob, Mara Meier, Rosmarie Caduff, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing dataArthur Dondi, Nico Borgsmüller, Pedro F Ferreira, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|July 5, 2014
PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension arrayTatiana Pochechueva, Alexander Chinarev, Nicolai Bovin, et al.
Nature Methods|October 31, 2025
High-resolution imaging mass cytometry to map subcellular structuresAlina Bollhagen, James Whipman, Ricardo Coelho, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2019
Outcome in serous ovarian cancer is not associated with LATS expressionCéline Montavon, Gregor R Stricker, Andreas Schoetzau, et al.
International Journal of Oncology|June 1, 2022
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell linesAndré Fedier, Nadia Maggi, Alessandra Tozzi, et al.
Plos One|April 5, 2013
Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell linesFrancis Jacob, Rea Guertler, Stephanie Naim, et al.
Molecular Oncology|October 5, 2020
High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancerFrancis Jacob, Rosa Lina Marchetti, André B Kind, et al.
Molecular & Cellular Proteomics : MCP|May 24, 2014
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation statusMerrina Anugraham, Francis Jacob, Sheri Nixdorf, et al.
Cancer Treatment Reviews|December 16, 2022
Low grade serous ovarian cancer - A rare disease with increasing therapeutic optionsTibor A Zwimpfer, Ori Tal, Franziska Geissler, et al.
Gynecologic Oncology|March 23, 2011
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical settingFrancis Jacob, Mara Meier, Rosmarie Caduff, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing dataArthur Dondi, Nico Borgsmüller, Pedro F Ferreira, et al.
Pageof 7